Search

Search Constraints

You searched for: Author/Creator Alcamí, José

Search Results

2. Hydroxytyrosol: a new class of microbicide displaying broad anti-HIV-1 activity. (28th November 2016)

3. Hydroxytyrosol: a new class of microbicide displaying broad anti-HIV-1 activity. (28th November 2016)

4. Immune response and reactogenicity after immunization with two-doses of an experimental COVID-19 vaccine (CVnCOV) followed by a third-fourth shot with a standard mRNA vaccine (BNT162b2): RescueVacs multicenter cohort study. (September 2022)

5. Immunogenic dynamics and SARS-CoV-2 variant neutralisation of the heterologous ChAdOx1-S/BNT162b2 vaccination: Secondary analysis of the randomised CombiVacS study. (August 2022)

6. Immunogenicity and reactogenicity of BNT162b2 booster in ChAdOx1-S-primed participants (CombiVacS): a multicentre, open-label, randomised, controlled, phase 2 trial. Issue 10295 (10th July 2021)

7. Immunogenicity and reactogenicity of BNT162b2 booster in ChAdOx1-S-primed participants (CombiVacS): a multicentre, open-label, randomised, controlled, phase 2 trial. Issue 10295 (10th July 2021)

8. Immunological and virological findings in a patient with exceptional post-treatment control: a case report. Issue 1 (January 2023)

9. Innenrücktitelbild: Structure‐Based Design of an RNA‐Binding p‐Terphenylene Scaffold that Inhibits HIV‐1 Rev Protein Function (Angew. Chem. 50/2013). (25th November 2013)

10. Inside Back Cover: Structure‐Based Design of an RNA‐Binding p‐Terphenylene Scaffold that Inhibits HIV‐1 Rev Protein Function (Angew. Chem. Int. Ed. 50/2013). Issue 50 (25th November 2013)